Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jeffrey Heier, M.D.


Efficacy of Ketorolac Tromethamine 0.3% vs. Control in Combination With Prednisolone Acetate 1.0% in the Prophylaxis of Cystoid Macular Edema After Retinal Detachment Repair
Part Time, 11/01/01 - 06/01/02

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Feltgen N, Ogura Y, Boscia F, Holz FG, Korobelnik JF, Brown DM, Heier JS, Stemper B, Rittenhouse KD, Asmus F, Ahlers C, Vitti R, Saroj N, Mitchell P. Impact of Baseline Retinal Nonperfusion and Macular Retinal Capillary Nonperfusion on Outcomes in the COPERNICUS and GALILEO Studies. Ophthalmol Retina. 2019 Jul; 3(7):553-560. PMID: 31277796.
  2. Goldberg RA, Crawford C, Heier JS. POSTOPERATIVE HEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS: A FORME FRUSTE VARIANT? Retin Cases Brief Rep. 2018 Fall; 12(4):305-306. PMID: 28045863.
    Citations:    Fields:    Translation:Humans
  3. Khanani AM, Duker JS, Heier JS, Kaiser PK, Joondeph BC, Kozma P, Rosberger DF, MacCumber M, Boyer DS, Pieramici DJ. Ocriplasmin Treatment Leads to Symptomatic Vitreomacular Adhesion/Vitreomacular Traction Resolution in the Real-World Setting: The Phase IV ORBIT Study. Ophthalmol Retina. 2019 Jan; 3(1):32-41. PMID: 30935657.
  4. Rosenfeld PJ, Dugel PU, Holz FG, Heier JS, Pearlman JA, Novack RL, Csaky KG, Koester JM, Gregory JK, Kubota R. Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Clinical Trial. Ophthalmology. 2018 Oct; 125(10):1556-1567. PMID: 29716784.
    Citations:    Fields:    
  5. Shah CP, Heier JS. Methodological and Efficacy Issues in a Randomized Clinical Trial Investigating Vitreous Floater Treatment-Reply. JAMA Ophthalmol. 2018 Apr 01; 136(4):449-450. PMID: 29522152.
    Citations:    Fields:    
  6. Campochiaro PA, Heier JS, Kherani S, Le-Halpere A, Scaria A. Ocular gene therapy for neovascular AMD: a new era? - Authors' reply. Lancet. 2017 11 11; 390(10108):2140. PMID: 29143750.
    Citations:    Fields:    Translation:Humans
  7. Shah CP, Heier JS. YAG Laser Vitreolysis vs Sham YAG Vitreolysis for Symptomatic Vitreous Floaters: A Randomized Clinical Trial. JAMA Ophthalmol. 2017 09 01; 135(9):918-923. PMID: 28727887.
    Citations:    Fields:    Translation:Humans
  8. Heier JS, Kherani S, Desai S, Dugel P, Kaushal S, Cheng SH, Delacono C, Purvis A, Richards S, Le-Halpere A, Connelly J, Wadsworth SC, Varona R, Buggage R, Scaria A, Campochiaro PA. Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial. Lancet. 2017 07 01; 390(10089):50-61. PMID: 28526489.
    Citations: 10     Fields:    Translation:HumansCellsCTClinical Trials
  9. Pulido JS, Heier JS, Marmorstein AD. Selumetinib in Plexiform Neurofibromas. N Engl J Med. 2017 03 23; 376(12):1195. PMID: 28332386.
    Citations:    Fields:    
  10. Ho AC, Albini TA, Brown DM, Boyer DS, Regillo CD, Heier JS. The Potential Importance of Detection of Neovascular Age-Related Macular Degeneration When Visual Acuity Is Relatively Good. JAMA Ophthalmol. 2017 Mar 01; 135(3):268-273. PMID: 28114653.
    Citations: 5     Fields:    Translation:Humans
  11. Anaya JA, Shah CP, Heier JS, Morley MG. Reply. Ophthalmology. 2017 03; 124(3):e28. PMID: 28219512.
    Citations:    Fields:    
  12. Wykoff CC, Marcus DM, Midena E, Korobelnik JF, Saroj N, Gibson A, Vitti R, Berliner AJ, Williams Liu Z, Zeitz O, Metzig C, Schmelter T, Heier JS. Intravitreal Aflibercept Injection in Eyes With Substantial Vision Loss After Laser Photocoagulation for Diabetic Macular Edema: Subanalysis of the VISTA and VIVID Randomized Clinical Trials. JAMA Ophthalmol. 2017 Feb 01; 135(2):107-114. PMID: 28006063.
    Citations:    Fields:    
  13. Clark WL, Boyer DS, Heier JS, Brown DM, Haller JA, Vitti R, Kazmi H, Berliner AJ, Erickson K, Chu KW, Soo Y, Cheng Y, Campochiaro PA. Reply. Ophthalmology. 2016 10; 123(10):e60-1. PMID: 27664917.
    Citations:    Fields:    
  14. Heier JS, Korobelnik JF, Brown DM, Schmidt-Erfurth U, Do DV, Midena E, Boyer DS, Terasaki H, Kaiser PK, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simader C, Soo Y, Schmelter T, Vitti R, Berliner AJ, Zeitz O, Metzig C, Holz FG. Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies. Ophthalmology. 2016 11; 123(11):2376-2385. PMID: 27651226.
    Citations: 11     Fields:    Translation:HumansCTClinical Trials
  15. Shah CP, Heier JS. Aflibercept for Diabetic Macular Edema in Eyes Previously Treated With Ranibizumab and/or Bevacizumab May Further Improve Macular Thickness. Ophthalmic Surg Lasers Imaging Retina. 2016 09 01; 47(9):836-9. PMID: 27631479.
    Citations: 9     Fields:    Translation:Humans
  16. Chew EY, Clemons TE, Harrington M, Bressler SB, Elman MJ, Kim JE, Garfinkel R, Heier JS, Brucker A, Boyer D. EFFECTIVENESS OF DIFFERENT MONITORING MODALITIES IN THE DETECTION OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: The Home Study, Report Number 3. Retina. 2016 Aug; 36(8):1542-7. PMID: 27243927.
    Citations:    Fields:    Translation:Humans
  17. Weber ML, Liang MC, Flaherty KT, Heier JS. Subretinal Fluid Associated With MEK Inhibitor Use in the Treatment of Systemic Cancer. JAMA Ophthalmol. 2016 Aug 01; 134(8):855-62. PMID: 27309887.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  18. Lally DR, Heier JS, Baumal C, Witkin AJ, Maler S, Shah CP, Reichel E, Waheed NK, Bussel I, Rogers A, Duker JS. Expanded spectral domain-OCT findings in the early detection of hydroxychloroquine retinopathy and changes following drug cessation. Int J Retina Vitreous. 2016; 2:18. PMID: 27847636.
    Citations: 1     
  19. Desai SJ, Heier JS. Chronically Retained Intraocular Air. JAMA Ophthalmol. 2016 07 01; 134(7):842-3. PMID: 27227754.
    Citations:    Fields:    Translation:Humans
  20. Jaffe GJ, Kaiser PK, Thompson D, Gibson A, Saroj N, Vitti R, Berliner AJ, Heier JS. Differential Response to Anti-VEGF Regimens in Age-Related Macular Degeneration Patients with Early Persistent Retinal Fluid. Ophthalmology. 2016 09; 123(9):1856-64. PMID: 27369111.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
    Citations: 2     Fields:    Translation:Humans
  22. Lally DR, Shah CP, Heier JS. Vascular endothelial growth factor and diabetic macular edema. Surv Ophthalmol. 2016 Nov - Dec; 61(6):759-768. PMID: 27045225.
    Citations: 9     Fields:    Translation:Humans
  23. Anaya JA, Shah CP, Heier JS, Morley MG. Outcomes after Failed Pneumatic Retinopexy for Retinal Detachment. Ophthalmology. 2016 May; 123(5):1137-42. PMID: 26952593.
    Citations: 1     Fields:    Translation:Humans
  24. Moshfeghi DM, Hariprasad SM, Marx JL, Thompson D, Soo Y, Gibson A, Saroj N, Vitti R, Heier JS. Effect of Fluid Status at Week 12 on Visual and Anatomic Outcomes at Week 52 in the VIEW 1 and 2 Trials. Ophthalmic Surg Lasers Imaging Retina. 2016 Mar; 47(3):238-44. PMID: 26985797.
    Citations: 3     Fields:    Translation:Humans
  25. Heier JS, Bressler NM, Avery RL, Bakri SJ, Boyer DS, Brown DM, Dugel PU, Freund KB, Glassman AR, Kim JE, Martin DF, Pollack JS, Regillo CD, Rosenfeld PJ, Schachat AP, Wells JA. Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice. JAMA Ophthalmol. 2016 Jan; 134(1):95-9. PMID: 26512939.
    Citations: 14     Fields:    Translation:Humans
  26. Clark WL, Boyer DS, Heier JS, Brown DM, Haller JA, Vitti R, Kazmi H, Berliner AJ, Erickson K, Chu KW, Soo Y, Cheng Y, Campochiaro PA. Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: 52-Week Results of the VIBRANT Study. Ophthalmology. 2016 Feb; 123(2):330-6. PMID: 26522708.
    Citations: 21     Fields:    Translation:HumansCTClinical Trials
  27. Weber ML, Heier JS. Choroidal Neovascularization Secondary to Myopia, Infection and Inflammation. Dev Ophthalmol. 2016; 55:167-75. PMID: 26501802.
    Citations: 4     Fields:    Translation:Humans
  28. Jaffe GJ, Schmitz-Valckenberg S, Boyer D, Heier J, Wolf-Schnurrbusch U, Staurenghi G, Schmidt-Erfurth U, Holz FG. Randomized Trial to Evaluate Tandospirone in Geographic Atrophy Secondary to Age-Related Macular Degeneration: The GATE Study. Am J Ophthalmol. 2015 Dec; 160(6):1226-34. PMID: 26310670.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  29. Brown DM, Schmidt-Erfurth U, Do DV, Holz FG, Boyer DS, Midena E, Heier JS, Terasaki H, Kaiser PK, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simader C, Soo Y, Schmelter T, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Zeitz O, Metzig C, Korobelnik JF. Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies. Ophthalmology. 2015 Oct; 122(10):2044-52. PMID: 26198808.
    Citations: 54     Fields:    Translation:HumansCTClinical Trials
  30. Gonzalez VH, Boyer DS, Schmidt-Erfurth U, Heier JS, Gordon C, Benz MS, Marcus DM, Sabates NR, Vitti R, Kazmi H, Berliner AJ, Soo Y, Zhu X, Moini H, Zeitz O, Sandbrink R, Do DV. Microperimetric assessment of retinal sensitivity in eyes with diabetic macular edema from a phase 2 study of intravitreal aflibercept. Retina. 2015 Apr; 35(4):687-94. PMID: 25621943.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  31. Goldberg RA, Lally DR, Heier JS. Oculocutaneous albinism. JAMA Ophthalmol. 2015 Mar; 133(3):e143518. PMID: 25763554.
    Citations:    Fields:    Translation:Humans
  32. Szelog JT, Lally DR, Heier JS. Natural history of Valsalva-induced subhyaloid hemorrhage. JAMA Ophthalmol. 2015 Feb; 133(2):e143268. PMID: 25674894.
    Citations:    Fields:    Translation:Humans
  33. Campochiaro PA, Sophie R, Tolentino M, Miller DM, Browning D, Boyer DS, Heier JS, Gambino L, Withers B, Brigell M, Peters K. Treatment of diabetic macular edema with an inhibitor of vascular endothelial-protein tyrosine phosphatase that activates Tie2. Ophthalmology. 2015 Mar; 122(3):545-54. PMID: 25439435.
    Citations: 18     Fields:    Translation:HumansCTClinical Trials
  34. Yuzawa M, Fujita K, Wittrup-Jensen KU, Norenberg C, Zeitz O, Adachi K, Wang EC, Heier J, Kaiser P, Chong V, Korobelnik JF. Improvement in vision-related function with intravitreal aflibercept: data from phase 3 studies in wet age-related macular degeneration. Ophthalmology. 2015 Mar; 122(3):571-8. PMID: 25439429.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  35. Campochiaro PA, Clark WL, Boyer DS, Heier JS, Brown DM, Vitti R, Kazmi H, Berliner AJ, Erickson K, Chu KW, Soo Y, Cheng Y, Haller JA. Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT study. Ophthalmology. 2015 Mar; 122(3):538-44. PMID: 25315663.
    Citations: 39     Fields:    Translation:HumansCTClinical Trials
  36. Wong SC, Lee TC, Heier JS. 23-Gauge endoscopic vitrectomy. Dev Ophthalmol. 2014; 54:108-19. PMID: 25196759.
    Citations: 1     Fields:    Translation:Humans
  37. Korobelnik JF, Do DV, Schmidt-Erfurth U, Boyer DS, Holz FG, Heier JS, Midena E, Kaiser PK, Terasaki H, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simader C, Soo Y, Schmelter T, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Zeitz O, Metzig C, Brown DM. Intravitreal aflibercept for diabetic macular edema. Ophthalmology. 2014 Nov; 121(11):2247-54. PMID: 25012934.
    Citations: 96     Fields:    Translation:HumansCTClinical Trials
  38. Goldberg RA, Shah CP, Wiegand TW, Heier JS. Noninfectious inflammation after intravitreal injection of aflibercept: clinical characteristics and visual outcomes. Am J Ophthalmol. 2014 Oct; 158(4):733-737.e1. PMID: 24983791.
    Citations: 7     Fields:    Translation:Humans
  39. Wong SC, Lee TC, Heier JS, Ho AC. Endoscopic vitrectomy. Curr Opin Ophthalmol. 2014 May; 25(3):195-206. PMID: 24713607.
    Citations: 4     Fields:    Translation:Humans
  40. Heier JS, Clark WL, Boyer DS, Brown DM, Vitti R, Berliner AJ, Kazmi H, Ma Y, Stemper B, Zeitz O, Sandbrink R, Haller JA. Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS study. Ophthalmology. 2014 Jul; 121(7):1414-1420.e1. PMID: 24679444.
    Citations: 50     Fields:    Translation:HumansCTClinical Trials
  41. Cho H, Weber ML, Shah CP, Heier JS. Initial utilization of aflibercept in exudative age-related macular degeneration. Eur J Ophthalmol. 2014 Jul-Aug; 24(4):576-81. PMID: 24706352.
    Citations: 1     Fields:    Translation:Humans
  42. Chew EY, Clemons TE, Bressler SB, Elman MJ, Danis RP, Domalpally A, Heier JS, Kim JE, Garfinkel RA. Randomized trial of the ForeseeHome monitoring device for early detection of neovascular age-related macular degeneration. The HOme Monitoring of the Eye (HOME) study design - HOME Study report number 1. Contemp Clin Trials. 2014 Mar; 37(2):294-300. PMID: 24530651.
    Citations: 9     Fields:    Translation:Humans
  43. Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof B, Ho A, Ogura Y, Schmidt-Erfurth U. Author reply: To PMID 23084240. Ophthalmology. 2014 Jan; 121(1):e5-e6. PMID: 24536092.
    Citations:    Fields:    Translation:Humans
  44. Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof B, Ho A, Ogura Y, Schmidt-Erfurth U. Author reply: To PMID 23084240. Ophthalmology. 2014 Jan; 121(1):e5-6. PMID: 24256893.
    Citations:    Fields:    Translation:Humans
  45. Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof B, Ho A, Ogura Y, Schmidt-Erfurth U. Author reply. Ophthalmology. 2014 Jan; 121(1):e5-e6. PMID: 30021266.
    Citations:    Fields:    
  46. Chew EY, Clemons TE, Bressler SB, Elman MJ, Danis RP, Domalpally A, Heier JS, Kim JE, Garfinkel R. Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study. Ophthalmology. 2014 Feb; 121(2):535-44. PMID: 24211172.
    Citations: 26     Fields:    Translation:HumansCTClinical Trials
  47. Stalmans P, Duker JS, Kaiser PK, Heier JS, Dugel PU, Gandorfer A, Sebag J, Haller JA. Oct-based interpretation of the vitreomacular interface and indications for pharmacologic vitreolysis. Retina. 2013 Nov-Dec; 33(10):2003-11. PMID: 23881226.
    Citations: 20     Fields:    Translation:Humans
  48. Campochiaro PA, Sophie R, Pearlman J, Brown DM, Boyer DS, Heier JS, Marcus DM, Feiner L, Patel A. Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study. Ophthalmology. 2014 Jan; 121(1):209-219. PMID: 24112944.
    Citations: 48     Fields:    Translation:HumansCTClinical Trials
  49. Goldman DR, Lee GD, Shah CP, Heier JS. Initial presentation of pseudoxanthoma elasticum. JAMA Ophthalmol. 2013 Oct; 131(10):1352. PMID: 24114133.
    Citations:    Fields:    Translation:Humans
  50. Schmidt-Erfurth U, Kaiser PK, Korobelnik JF, Brown DM, Chong V, Nguyen QD, Ho AC, Ogura Y, Simader C, Jaffe GJ, Slakter JS, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, Anderesi M, Sowade O, Zeitz O, Norenberg C, Sandbrink R, Heier JS. Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies. Ophthalmology. 2014 Jan; 121(1):193-201. PMID: 24084500.
    Citations: 97     Fields:    Translation:HumansCTClinical Trials
  51. Goldman DR, Shah CP, Heier JS. Expanded criteria for pneumatic retinopexy and potential cost savings. Ophthalmology. 2014 Jan; 121(1):318-326. PMID: 23953099.
    Citations: 8     Fields:    Translation:Humans
  52. Cho H, Shah CP, Weber M, Heier JS. Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab. Br J Ophthalmol. 2013 Aug; 97(8):1032-5. PMID: 23766432.
    Citations: 54     Fields:    Translation:Humans
  53. Nguyen QD, Do DV, Haller JA, Heier JS, Kaiser PK. Putting theories and results into practice: managing cases. Ophthalmology. 2013 May; 120(5 Suppl):S16-22. PMID: 23642782.
    Citations:    Fields:    Translation:Humans
  54. Heier JS. Neovascular age-related macular degeneration: individualizing therapy in the era of anti-angiogenic treatments. Ophthalmology. 2013 May; 120(5 Suppl):S23-5. PMID: 23642783.
    Citations: 4     Fields:    Translation:Humans
  55. Perlee LT, Bansal AT, Gehrs K, Heier JS, Csaky K, Allikmets R, Oeth P, Paladino T, Farkas DH, Rawlings PL, Hageman GS. Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophy. Ophthalmology. 2013 Sep; 120(9):1880-92. PMID: 23523162.
    Citations: 8     Fields:    Translation:Humans
  56. Busbee BG, Ho AC, Brown DM, Heier JS, Suñer IJ, Li Z, Rubio RG, Lai P. Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration. Ophthalmology. 2013 May; 120(5):1046-56. PMID: 23352196.
    Citations: 68     Fields:    Translation:HumansCTClinical Trials
  57. Campochiaro PA, Channa R, Berger BB, Heier JS, Brown DM, Fiedler U, Hepp J, Stumpp MT. Treatment of diabetic macular edema with a designed ankyrin repeat protein that binds vascular endothelial growth factor: a phase I/II study. Am J Ophthalmol. 2013 Apr; 155(4):697-704, 704.e1-2. PMID: 23218689.
    Citations: 23     Fields:    Translation:HumansCellsCTClinical Trials
  58. Brown DM, Heier JS, Clark WL, Boyer DS, Vitti R, Berliner AJ, Zeitz O, Sandbrink R, Zhu X, Haller JA. Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study. Am J Ophthalmol. 2013 Mar; 155(3):429-437.e7. PMID: 23218699.
    Citations: 52     Fields:    Translation:HumansCTClinical Trials
  59. Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof B, Ho A, Ogura Y, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, Anderesi M, Groetzbach G, Sommerauer B, Sandbrink R, Simader C, Schmidt-Erfurth U. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology. 2012 Dec; 119(12):2537-48. PMID: 23084240.
    Citations: 294     Fields:    Translation:HumansCTClinical Trials
  60. Heier J. Ask the doctor. I have been diagnosed with macular degeneration and cataracts in both eyes. Could cataract surgery worsen my macular degeneration? Harv Health Lett. 2012 May; 37(7):8. PMID: 22737742.
    Citations:    Fields:    Translation:Humans
  61. Do DV, Nguyen QD, Boyer D, Schmidt-Erfurth U, Brown DM, Vitti R, Berliner AJ, Gao B, Zeitz O, Ruckert R, Schmelter T, Sandbrink R, Heier JS. One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema. Ophthalmology. 2012 Aug; 119(8):1658-65. PMID: 22537617.
    Citations: 79     Fields:    Translation:HumansCTClinical Trials
  62. Boyer D, Heier J, Brown DM, Clark WL, Vitti R, Berliner AJ, Groetzbach G, Zeitz O, Sandbrink R, Zhu X, Beckmann K, Haller JA. Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS study. Ophthalmology. 2012 May; 119(5):1024-32. PMID: 22440275.
    Citations: 41     Fields:    Translation:HumansCTClinical Trials
  63. Heier JS, Campochiaro PA, Yau L, Li Z, Saroj N, Rubio RG, Lai P. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. Ophthalmology. 2012 Apr; 119(4):802-9. PMID: 22301066.
    Citations: 75     Fields:    Translation:Humans
  64. Do DV, Gower EW, Cassard SD, Boyer D, Bressler NM, Bressler SB, Heier JS, Jefferys JL, Singerman LJ, Solomon SD. Detection of new-onset choroidal neovascularization using optical coherence tomography: the AMD DOC Study. Ophthalmology. 2012 Apr; 119(4):771-8. PMID: 22297028.
    Citations: 19     Fields:    Translation:Humans
  65. Heier JS. Ask the doctor. I have wet macular degeneration. I am trying to decide between Avastin and Lucentis. Which drug is better? Harv Health Lett. 2011 Dec; 37(2):6-7. PMID: 27024308.
    Citations:    Fields:    Translation:Humans
  66. Chiang A, Kaiser RS, Avery RL, Dugel PU, Eliott D, Shah SP, Heier J, Duker J, Hu AY, Schwartz SD, Scott IU, Pollack JS, Faia LJ, Williams GA. Endophthalmitis in microincision vitrectomy: outcomes of gas-filled eyes. Retina. 2011 Sep; 31(8):1513-7. PMID: 21878799.
    Citations: 4     Fields:    Translation:Humans
  67. Haller JA, Bandello F, Belfort R, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitcup SM, Li J. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology. 2011 Dec; 118(12):2453-60. PMID: 21764136.
    Citations: 131     Fields:    Translation:HumansCTClinical Trials
  68. Brown DM, Heier JS, Ciulla T, Benz M, Abraham P, Yancopoulos G, Stahl N, Ingerman A, Vitti R, Berliner AJ, Yang K, Nguyen QD. Primary endpoint results of a phase II study of vascular endothelial growth factor trap-eye in wet age-related macular degeneration. Ophthalmology. 2011 Jun; 118(6):1089-97. PMID: 21640257.
    Citations: 27     Fields:    Translation:HumansCTClinical Trials
  69. Heier JS, Boyer D, Nguyen QD, Marcus D, Roth DB, Yancopoulos G, Stahl N, Ingerman A, Vitti R, Berliner AJ, Yang K, Brown DM. The 1-year results of CLEAR-IT 2, a phase 2 study of vascular endothelial growth factor trap-eye dosed as-needed after 12-week fixed dosing. Ophthalmology. 2011 Jun; 118(6):1098-106. PMID: 21640258.
    Citations: 41     Fields:    Translation:HumansCTClinical Trials
  70. Do DV, Schmidt-Erfurth U, Gonzalez VH, Gordon CM, Tolentino M, Berliner AJ, Vitti R, Rückert R, Sandbrink R, Stein D, Yang K, Beckmann K, Heier JS. The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema. Ophthalmology. 2011 Sep; 118(9):1819-26. PMID: 21546089.
    Citations: 67     Fields:    Translation:HumansCTClinical Trials
  71. Heier JS. Ask the doctor. I think I may have cataracts. I heard somewhere that they need to be ripe before I get surgery. Is that true? Harv Health Lett. 2011 May; 36(7):3. PMID: 21695853.
    Citations:    Fields:    Translation:Humans
  72. Zhang K, Hopkins JJ, Heier JS, Birch DG, Halperin LS, Albini TA, Brown DM, Jaffe GJ, Tao W, Williams GA. Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration. Proc Natl Acad Sci U S A. 2011 Apr 12; 108(15):6241-5. PMID: 21444807.
    Citations: 68     Fields:    Translation:HumansCellsCTClinical Trials
  73. Heier JS, Brown D, Ciulla T, Abraham P, Bankert JM, Chong S, Daniel PE, Kim IK. Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: a phase I clinical trial. Ophthalmology. 2011 Jan; 118(1):111-8. PMID: 20678799.
    Citations: 15     Fields:    Translation:HumansCTClinical Trials
  74. Shingleton BJ, Marvin AC, Heier JS, O'Donoghue MW, Laul A, Wolff B, Rowland A. Pseudoexfoliation: High risk factors for zonule weakness and concurrent vitrectomy during phacoemulsification. J Cataract Refract Surg. 2010 Aug; 36(8):1261-9. PMID: 20656147.
    Citations: 4     Fields:    Translation:Humans
  75. Morley MG, Nguyen JK, Heier JS, Shingleton BJ, Pasternak JF, Bower KS. Blast eye injuries: a review for first responders. Disaster Med Public Health Prep. 2010 Jun; 4(2):154-60. PMID: 20526138.
    Citations: 8     Fields:    Translation:Humans
  76. Heier JS. By the way, doctor. My 78-year-old husband has wet macular degeneration. He is being treated with a drug called Avastin. Is that a good choice? Harv Health Lett. 2010 May; 35(7):6. PMID: 20583361.
    Citations:    Fields:    Translation:Humans
  77. Haller JA, Bandello F, Belfort R, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010 Jun; 117(6):1134-1146.e3. PMID: 20417567.
    Citations: 191     Fields:    Translation:Humans
  78. Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC, Murahashi WY, Rubio RG. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 2010 Jun; 117(6):1102-1112.e1. PMID: 20398941.
    Citations: 175     Fields:    Translation:HumansCTClinical Trials
  79. Zahn G, Volk K, Lewis GP, Vossmeyer D, Stragies R, Heier JS, Daniel PE, Adamis AP, Chapin EA, Fisher SK, Holz FG, Löffler KU, Knolle J. Assessment of the integrin alpha5beta1 antagonist JSM6427 in proliferative vitreoretinopathy using in vitro assays and a rabbit model of retinal detachment. Invest Ophthalmol Vis Sci. 2010 Feb; 51(2):1028-35. PMID: 19815730.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  80. Heier JS, Awh CC, Busbee BG, Waterbury LD, Daniel P, Stoller GL, Cleary TS. Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%. Retina. 2009 Oct; 29(9):1310-3. PMID: 19934822.
    Citations: 7     Fields:    Translation:Humans
  81. Boyer DS, Heier JS, Brown DM, Francom SF, Ianchulev T, Rubio RG. A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration. Ophthalmology. 2009 Sep; 116(9):1731-9. PMID: 19643495.
    Citations: 71     Fields:    Translation:HumansCTClinical Trials
  82. Ahmad FK, Morley MG, Berry A, Wiegand TW, Heier JS, Morley EF, Sanguansak T, Topping TM, Frederick AR, Sang DN, Hughes MS, Cleary TS. Effects of ranibizumab on exudative disciform scars. Ophthalmic Surg Lasers Imaging. 2009 Jul-Aug; 40(4):366-72. PMID: 19634740.
    Citations:    Fields:    Translation:Humans
  83. Heier JS. Pathology beyond neovascularization: new targets in age-related macular degeneration. Retina. 2009 Jun; 29(6 Suppl):S39-41. PMID: 19553799.
    Citations:    Fields:    Translation:Humans
  84. Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. Ophthalmology. 2009 Jan; 116(1):57-65.e5. PMID: 19118696.
    Citations: 274     Fields:    Translation:HumansCTClinical Trials
  85. Fintak DR, Shah GK, Blinder KJ, Regillo CD, Pollack J, Heier JS, Hollands H, Sharma S. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina. 2008 Nov-Dec; 28(10):1395-9. PMID: 18827737.
    Citations: 56     Fields:    Translation:HumansCells
  86. Hudson HL, Stulting RD, Heier JS, Lane SS, Chang DF, Singerman LJ, Bradford CA, Leonard RE. Implantable telescope for end-stage age-related macular degeneration: long-term visual acuity and safety outcomes. Am J Ophthalmol. 2008 Nov; 146(5):664-673. PMID: 18760765.
    Citations: 8     Fields:    Translation:Humans
  87. Wittpenn JR, Silverstein S, Heier J, Kenyon KR, Hunkeler JD, Earl M. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients. Am J Ophthalmol. 2008 Oct; 146(4):554-560. PMID: 18599019.
    Citations: 24     Fields:    Translation:Humans
  88. Heier JS, Boyer DS, Ciulla TA, Ferrone PJ, Jumper JM, Gentile RC, Kotlovker D, Chung CY, Kim RY. Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study. Arch Ophthalmol. 2006 Nov; 124(11):1532-42. PMID: 17101999.
    Citations: 64     Fields:    Translation:HumansCTClinical Trials
  89. Subramanian ML, Heier JS, Esrick E, Devaiah AK, Topping TM, Frederick AR, Morley MG. Preoperative visual acuity as a prognostic indicator for laser treatment of macular edema due to branch retinal vein occlusion. Ophthalmic Surg Lasers Imaging. 2006 Nov-Dec; 37(6):462-7. PMID: 17152539.
    Citations: 5     Fields:    Translation:Humans
  90. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006 Oct 05; 355(14):1419-31. PMID: 17021318.
    Citations: 1148     Fields:    Translation:HumansCTClinical Trials
  91. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006 Oct 05; 355(14):1432-44. PMID: 17021319.
    Citations: 718     Fields:    Translation:Humans
  92. Chun DW, Heier JS, Topping TM, Duker JS, Bankert JM. A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema. Ophthalmology. 2006 Oct; 113(10):1706-12. PMID: 17011952.
    Citations: 68     Fields:    Translation:Humans
  93. Hudson HL, Lane SS, Heier JS, Stulting RD, Singerman L, Lichter PR, Sternberg P, Chang DF. Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results. Ophthalmology. 2006 Nov; 113(11):1987-2001. PMID: 16989902.
    Citations: 17     Fields:    Translation:Humans
  94. Rosenfeld PJ, Heier JS, Hantsbarger G, Shams N. Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration. Ophthalmology. 2006 Apr; 113(4):623.e1. PMID: 16581423.
    Citations: 40     Fields:    Translation:HumansCTClinical Trials
  95. Heier JS, Antoszyk AN, Pavan PR, Leff SR, Rosenfeld PJ, Ciulla TA, Dreyer RF, Gentile RC, Sy JP, Hantsbarger G, Shams N. Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study. Ophthalmology. 2006 Apr; 113(4):633.e1-4. PMID: 16483659.
    Citations: 79     Fields:    Translation:HumansCTClinical Trials
  96. Chun DW, Heier JS, Raizman MB. Visual prosthetic device for bilateral end-stage macular degeneration. Expert Rev Med Devices. 2005 Nov; 2(6):657-65. PMID: 16293092.
    Citations: 1     Fields:    Translation:Humans
  97. Alster Y, Bressler NM, Bressler SB, Brimacombe JA, Crompton RM, Duh YJ, Gabel VP, Heier JS, Ip MS, Loewenstein A, Packo KH, Stur M, Toaff T. Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization study. Ophthalmology. 2005 Oct; 112(10):1758-65. PMID: 16154198.
    Citations: 11     Fields:    Translation:Humans
  98. Esrick E, Subramanian ML, Heier JS, Devaiah AK, Topping TM, Frederick AR, Morley MG. Multiple laser treatments for macular edema attributable to branch retinal vein occlusion. Am J Ophthalmol. 2005 Apr; 139(4):653-7. PMID: 15808160.
    Citations: 7     Fields:    Translation:Humans
  99. Kim RW, Heier JS. Innovative treatments for exudative age-related macular degeneration. Int Ophthalmol Clin. 2004; 44(4):41-50. PMID: 15577563.
    Citations: 1     Fields:    Translation:Humans
  100. Neuber M, Heier J, Vordemvenne T, Schult M. [Surgical indications in intraosseous lipoma of the calcaneus. Case report and critical review of the literature]. Unfallchirurg. 2004 Jan; 107(1):59-63. PMID: 14749853.
    Citations: 2     Fields:    Translation:Humans
  101. Heier JS, Topping TM, Baumann W, Dirks MS, Chern S. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema. Ophthalmology. 2000 Nov; 107(11):2034-8;discussion 2039. PMID: 11054327.
    Citations: 25     Fields:    Translation:HumansCTClinical Trials
  102. McColgin AZ, Heier JS. Control of intraocular inflammation associated with cataract surgery. Curr Opin Ophthalmol. 2000 Feb; 11(1):3-6. PMID: 10724825.
    Citations: 14     Fields:    Translation:Humans
  103. Durand ML, Heier JS. Endophthalmitis. Curr Clin Top Infect Dis. 2000; 20:271-97. PMID: 10943529.
    Citations: 2     Fields:    Translation:HumansAnimals
  104. Heier J, Cheetham JK, Degryse R, Dirks MS, Caldwell DR, Silverstone DE, Rosenthal A. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial. Am J Ophthalmol. 1999 Mar; 127(3):253-9. PMID: 10088733.
    Citations: 15     Fields:    Translation:HumansCTClinical Trials
  105. Heier JS, Topping TM, Frederick AR, Morley MG, Millay R, Pesavento RD. Visual and surgical outcomes of retinal detachment following macular hole repair. Retina. 1999; 19(2):110-5. PMID: 10213235.
    Citations: 5     Fields:    Translation:Humans
  106. Postel EA, Pulido JS, Byrnes GA, Heier J, Waterhouse W, Han DP, Mieler WF, Guse C, Wipplinger W. Long-term follow-up of iatrogenic phototoxicity. Arch Ophthalmol. 1998 Jun; 116(6):753-7. PMID: 9639443.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  107. Heier JS, Steinert RF, Frederick AR. Cystoid macular edema associated with latanoprost use. Arch Ophthalmol. 1998 May; 116(5):680-2. PMID: 9596510.
    Citations: 5     Fields:    Translation:Humans
  108. Heier JS, Gardner TA, Hawes MJ, McGuire KA, Walton WT, Stock J. Proptosis as the initial presentation of fungal sinusitis in immunocompetent patients. Ophthalmology. 1995 May; 102(5):713-7. PMID: 7777269.
    Citations: 7     Fields:    Translation:HumansAnimals
  109. Heier JS, Walton WT, Enzenauer RW, Rice W, Tuman D. Wound strength comparison of a 5.1-millimeter no-stitch with a 7.0-millimeter sutured incision in human cadaver globes. Ophthalmic Surg. 1994 Nov-Dec; 25(10):685-7. PMID: 7898860.
    Citations:    Fields:    Translation:Humans
  110. Heier JS, Dragoo RA, Enzenauer RW, Waterhouse WJ. Screening for ocular toxicity in asymptomatic patients treated with tamoxifen. Am J Ophthalmol. 1994 Jun 15; 117(6):772-5. PMID: 7880223.
    Citations: 7     Fields:    Translation:HumansCells
  111. Mader TH, Aragones JV, Chandler AC, Hazlehurst JA, Heier J, Kingham JD, Stein E. Ocular and ocular adnexal injuries treated by United States military ophthalmologists during Operations Desert Shield and Desert Storm. Ophthalmology. 1993 Oct; 100(10):1462-7. PMID: 8414405.
    Citations: 2     Fields:    Translation:Humans
  112. Heier JS, Enzenauer RW, Wintermeyer SF, Delaney M, LaPiana FP. Ocular injuries and diseases at a combat support hospital in support of Operations Desert Shield and Desert Storm. Arch Ophthalmol. 1993 Jun; 111(6):795-8. PMID: 8512480.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Heier's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (321)
Co-Authors (10)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.